Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
100%(3 trials)

Phase Distribution

Ph phase_2
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

not_yet_recruiting125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_2

PDC-1421 Treatment in Adult Patients With ADHD

NCT05202327
not_yet_recruitingphase_1

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

NCT03833206
completedphase_2

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT02699086
completedphase_2

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

NCT02395978

Clinical Trials (4)

Showing 4 of 4 trials
NCT05202327Phase 2

PDC-1421 Treatment in Adult Patients With ADHD

Completed
NCT03833206Phase 1

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Not Yet Recruiting
NCT02699086Phase 2

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

Completed
NCT02395978Phase 2

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4